Tampa FL 肥胖症临床试验
8项针对 肥胖症的研究正在 Tampa及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Tampa
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Tampa
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
招募中3 期
- Jedidiah Clinical Research, Tampa
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research, Tampa
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- St Joseph's Hospital Foundation, Tampa
- Tampa Cardiovascular Interventions and Research, Tampa
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Tampa
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
招募中3 期欢迎健康志愿者
- Vanda Investigational Site, Tampa
FRESH-EATS Project
招募中欢迎健康志愿者
- University of South Florida, Tampa
其他城市的 肥胖症试验
- Houston, TX43 项研究
- Chicago, IL41 项研究
- New York City, NY40 项研究
- San Antonio, TX40 项研究
- Washington, DC33 项研究
- Orlando, FL31 项研究
- Dallas, TX30 项研究
- Boston, MA28 项研究
- Las Vegas, NV27 项研究
- Miami, FL27 项研究
- Baltimore, MD25 项研究
- Jacksonville, FL25 项研究
Tampa的其他研究
- 非小细胞肺癌51 项研究
- 乳腺癌43 项研究
- 癌症（所有类型）39 项研究
- 结直肠癌33 项研究
- 转移性癌症29 项研究
- 肺癌29 项研究
- 急性髓系白血病29 项研究
- 胰腺癌26 项研究
- 卵巢癌21 项研究
- 骨髓增生异常综合征19 项研究
- 黑色素瘤19 项研究
- 心力衰竭18 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。